Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 670

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 670
---
, used or operated by the Company or any of its Subsidiaries; 8.10.18 “ Company Recommendation ” means the recommendation of the Company Board that the shareholders of the Company approve this Agreement and the transactions contemplated herein, including the Merger; 8.10.19 “Company Requisite Vote ” means the affirmative vote of the holders of Ordinary Shares satisfying the applicable majority, supermajority or other applicable requirements, represented in person or by proxy at the Company Shareholders Meeting, approving the Merger and the transactions contemplated herein, in accordance with the governing documents of the Company, the rules and regulations of TASE, and applicable Law. 8.10.20 “Competition Law ” means the Israel Economic Competition Law [1988]; 8.10.21 “ Confidentiality Agreement ” means that certain Mutual Non-Disclosure Agreement entered into as of July 2, 2024 by and between Parent and the Company; 8.10.22 “ Consent ” means any filings, permits, licenses, permits, waivers, orders, authorizations, consents, and approvals; 8.10.23 “ Contract ” means any agreement, contract, instrument, note, bond, mortgage, commitment, lease, guaranty, indenture, license, or other instrument, arrangement or understanding (and all amendments, side letters, modifications, and supplements thereto) between parties or by one party in favor of another party, whether written or oral; 8.10.24 “ COVID-19 ” means SARS-CoV-2 or COVID-19, and any evolutions or strains thereof; 8.10.25 “ COVID Related Deferrals ” means any Tax liabilities or other amounts for or allocable to any Taxable period (or portion thereof) ending on or prior to the Closing Date, the payment of which is deferred, on or prior to the Closing Date, to a Taxable period (or portion thereof) beginning after the Closing Date pursuant to any Applicable Law related to COVID-19 or executive order or Presidential Memorandum (including the Presidential Memorandum described in IRS Notice 2020-65) related to COVID-19; 8.10.26 “ CVR Agreement ” means the Contingent Value Rights Agreement, in substantially the form attached hereto as Exhibit B , to be entered into between Parent and VStock Transfer, LLC (or such other nationally recognized rights agent agreed to between Parent and the Company) (the “ Rights Agent ”), with such revisions